Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic Resistance

被引:1
|
作者
Larsson, Sofie [1 ,2 ]
Edlund, Charlotta [1 ]
Naucler, Pontus [3 ]
Svensson, Mikael [2 ]
Ternhag, Anders [1 ,3 ]
机构
[1] Publ Hlth Agcy Sweden, Solna, Sweden
[2] Univ Gothenburg, Sch Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden
[3] Karolinska Inst, Dept Med Solna, Stockholm, Sweden
关键词
URINARY-TRACT-INFECTIONS; HEALTH; REIMBURSEMENT; EPIDEMIOLOGY; IMPACT;
D O I
10.1007/s40258-022-00748-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Antibiotic resistance has been listed as one of the biggest threats to global health today. A recent study has shown that treating febrile urinary tract infections with temocillin instead of cefotaxime leads to a reduced selection of antibiotic-resistant bacteria. However, a potential challenge with prioritizing temocillin over cefotaxime is the cost consequences. Objective This study aimed to assess the cost effectiveness of using temocillin compared to cefotaxime in treating febrile urinary tract infections in a model that takes the emergence of antibiotic resistance into account. Methods We used a Markov cohort model to estimate the costs and health effects of temocillin and cefotaxime treatment in febrile urinary tract infections in a Swedish setting. Health effects were assessed in terms of quality-adjusted life-years, and the primary outcome was the cost per quality-adjusted life-year gained with temocillin compared to cefotaxime. We used a 5-year time horizon. Results The model results showed that temocillin treatment led to better health outcomes at a higher total cost. The cost per quality-adjusted life-year gained was approximately 38,400 EUR. Results from the sensitivity analysis suggested a 63% probability of temocillin being cost effective at a threshold of 50,000 EUR. Furthermore, results showed that the cost effectiveness of temocillin in febrile urinary tract infections is highly dependent on the drug cost. Conclusions As antibiotic consumption is a driving force of resistance, it is essential to consider the development of resistance when studying the health economic consequences of antibiotic treatments. In doing so, this study found temocillin to be cost effective for febrile urinary tract infections.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 50 条
  • [1] Role of antibiotic resistance in urinary tract infection management: a cost-effectiveness analysis
    Wang, Rui
    LaSala, Christine
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (05) : 550.e1 - 550.e10
  • [2] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN
    Taheri, Saeed
    Heidari, Elham
    Aivazi, Mohammad Ali
    Shams-Beyranvand, Mehran
    Varmaghani, Mehdi
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 576 - 583
  • [3] Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings
    Toumazis, Iakovos
    Tsai, Emily B.
    Erdogan, S. Ayca
    Han, Summer S.
    Wan, Wenshuai
    Leung, Ann
    Plevritis, Sylvia K.
    JNCI CANCER SPECTRUM, 2019, 3 (03)
  • [4] Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia: A Cost-Effectiveness Analysis
    Li, Edward
    Mezzio, Dylan J.
    Campbell, David
    Campbell, Kim
    Lyman, Gary H.
    JCO ONCOLOGY PRACTICE, 2021, 17 (08) : 511 - E1245
  • [5] Cost-Effectiveness of Preoperative Nasal Mupirocin Treatment in Preventing Surgical Site Infection in Patients Undergoing Total Hip and Knee Arthroplasty: A Cost-Effectiveness Analysis
    Courville, Xan F.
    Tomek, Ivan M.
    Kirkland, Kathryn B.
    Birhle, Marian
    Kantor, Stephen R.
    Finlayson, Samuel R. G.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (02) : 152 - 159
  • [6] Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance
    Lee, Kyueun
    Drekonja, Dimitri M.
    Enns, Eva A.
    VALUE IN HEALTH, 2018, 21 (03) : 310 - 317
  • [7] Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis
    Noorbakhsh, Kathleen A.
    Ramgopal, Sriram
    Rixe, Nancy S.
    Dunnick, Jennifer
    Smith, Kenneth J.
    BMC PEDIATRICS, 2022, 22 (01)
  • [8] Cost-effectiveness of antibiotic prophylaxis for dental patients with prosthetic joints Comparisons of antibiotic regimens for patients with total hip arthroplasty
    Skaar, Daniel D.
    Park, Taehwan
    Swiontkowski, Marc F.
    Kuntz, Karen M.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2015, 146 (11) : 830 - 839
  • [9] Treatment Evolution and New Standards of Care: Implications for Cost-Effectiveness Analysis
    Shechter, Steven M.
    MEDICAL DECISION MAKING, 2011, 31 (01) : 35 - 42
  • [10] Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C
    Chou, Jacquelyn W.
    Graf, Marlon
    Espinosa, Oliver Diaz
    Brewer, Iris
    Heim, Zachary
    Baumgardner, James
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (12) : 696 - 703